Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Aditya Birla Sun Life PSU Equity Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaABSL
NAV₹666.3420₹41.7400
NAV date20 Nov 202620 Nov 2026
History13.9 years6.9 years
Expense ratio1.0%0.7%
Stars★★★★★★★★★★
Growth Score75.2066.50

Returns

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
1 month+11.40%+9.73%
3 months+3.74%+4.35%
6 months+8.55%+4.85%
YTD+16.94%+9.58%
1 year+15.26%+9.27%
3 years (CAGR)+17.96%+20.02%
5 years (CAGR)+15.40%+23.66%
10 years (CAGR)+16.61%—
Since launch+17.63%+22.95%

Risk

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
Volatility14.1%22.7%
Downside volatility9.0%13.2%
Sharpe0.810.60
Sortino1.281.02
Calmar1.220.75
Return / risk1.270.88
Deepest fall−24.02%−33.76%
Days to recover445265
Below its high+0.00%−0.43%

Against benchmark

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
Alpha−1.86%—
Beta0.89—
R²89.5%—
Up capture85.2%—
Down capture88.7%—
Tracking error4.8%—
Information ratio−0.69—
Treynor0.12—

Consistency

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
Best 1-year+90.70%+111.48%
Middle 1-year+13.13%+25.15%
Worst 1-year−15.12%−15.09%
1-year periods with a loss23.2%12.2%
Middle 3-year+19.82%+32.42%
Positive months63.9%55.6%
Best day+3.40%+6.93%
Worst day−3.21%−14.63%
Worst 5% day−1.38%−2.01%
Positive days53.7%56.1%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundAditya Birla Sun Life PSU Equity Fund
5-year XIRR+18.24%+20.92%
5-year value₹9,54,076₹10,19,664
3-year XIRR+14.26%+10.45%
1-year XIRR+22.08%+11.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth